Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

See Remarks

Chief Executive Officer

Rallybio Corporation, a clinical-stage biotechnology company, engages in identifying, accelerating, and development of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT). The company is also developing RLYB211, a polyclonal anti-HPA-1a antibody that is in a Phase 1/2 clinical trial for the prevention of FNAIT; RLYB114, a pegylated complement factor 5 (C5)-targeted Affibody molecule in preclinical development for the treatment of complement-mediated ophthalmic diseases; RLYB116, a subcutaneously administered inhibitor of C5 for the treatment of patients with paroxysmal nocturnal hemoglobinuria and generalized myasthenia gravis; and RLYB331, a preclinical antibody, for the treatment of severe anemia with ineffective erythropoiesis and iron overload. Rallybio has collaboration with Exscientia for the development of small molecule therapeutics for rare diseases. Rallybio Corporation was founded in 2018 and is headquartered in New Haven, Connecticut.

Rallybio Corporation, a clinical-stage biotechnology company, engages in identifying, accelerating, and development of life-transforming t...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-03-14	Premium	bought	Premium	Premium	Premium	See Remarks
2023-03-07	Premium	sold	Premium	Premium	Premium	-
2023-03-07	Premium	sold	Premium	Premium	Premium	-
2022-06-03	Premium	sold	Premium	Premium	Premium	-
2022-06-03	Premium	sold	Premium	Premium	Premium	-
2022-06-03	Premium	sold	Premium	Premium	Premium	-
2022-06-03	Premium	sold	Premium	Premium	Premium	-
2022-05-23	Premium	sold	Premium	Premium	Premium	-
2022-05-23	Premium	sold	Premium	Premium	Premium	-
2022-05-23	Premium	sold	Premium	Premium	Premium	-
2022-05-23	Premium	sold	Premium	Premium	Premium	-
2022-03-21	Premium	bought	Premium	Premium	Premium	See Remarks
2022-02-08	Premium	sold	Premium	Premium	Premium	-
2022-02-08	Premium	sold	Premium	Premium	Premium	-
2022-02-08	Premium	sold	Premium	Premium	Premium	-
2022-01-19	Premium	bought	Premium	Premium	Premium	See Remarks
2022-01-13	Premium	bought	Premium	Premium	Premium	See Remarks
2022-01-12	Premium	bought	Premium	Premium	Premium	See Remarks
2022-01-11	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-01-10	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-01-07	Premium	bought	Premium	Premium	Premium	See Remarks
2021-08-02	Premium	bought	Premium	Premium	Premium	-
2021-08-02	Premium	bought	Premium	Premium	Premium	-
2021-08-02	Premium	acquired	Premium	Premium	Premium	-
2021-08-02	Premium	bought	Premium	Premium	Premium	-

RLYB - Rallybio Corporation Stock Price, Fair Value and News

Latest Insider Trading transactions for RLYB